抗乙肝胎盘转移因子防治肝硬变的探讨  

^RPEVENTION OF LIVER CIRRHJOSIS WITH ANTI-HEPATITIS B PLACENTA TRANSFER FACTOR

作　　者：张光曙[1] 赵世科 赵汇川[1] 杜庆岭[1] 于建国[1] 林国贤[1] 

机构地区：[1]解放军第88医院

出　　处：《解放军医学杂志》1995年第2期111-114,共4页Medical Journal of Chinese People's Liberation Army

摘　　要：乙型肝炎１００例经抗乙肝胎盘转移因子治疗获得临床治愈后，肝活检复查证明急性乙肝平均３个月后肝组织病理基本正常者仅１５．４％，明显进步６１．５％，提示出院后仍需巩固治疗。慢活肝和慢活肝伴早期肝硬变者经本剂治后，肝活检复查示病理形态明显进步者，观察组显著多于对照组，早期肝硬变的病理改变治后可获消退，代偿期肝硬变的病理形态改变亦可获进步。因此，初步证明肝硬变的病理形态是可逆转的，抗乙肝胎盘转移因子可以提高逆转率。The results of liver biopsy in 100 cases of hepatitis B patients treated with anti-hepatitis B placenta transfer factor(PSTF ) about 3 months in average after clinical recovery。 It have proved that on- ly 15.4% of the acute hepatitis B patients showed basically normal and 61.5% obvious improvement. The marked improvement of CAH and CAH with tendency to result in cirrhosis of the study group was much more evident than the control group, and it has been revealed that the characteristics of liver cirrhosis could also be improved. So, it has been proved primarily that the pathological characterlstics of liver cirrhosis might be reversible and PSTF could raise the reverse rate。

关 键 词：抗乙肝胎盘 转移因子 乙型肝炎 肝活检 肝硬变 

分 类 号：R512.620.5[医药卫生—内科学] R575.205[医药卫生—临床医学]